Champions Oncology Long Term Debt

Champions Oncology (CSBR) currently reports a long-term debt of $3M as of April 2026. That compares with $4.6M in the prior-year period — down 35.3% year over year. Use the charts on this page to explore Champions Oncology's long-term debt history and peer comparisons.

Champions Oncology's long-term debt decreased from $4.6M to $3M — a 35.3% year-over-year decrease (period ending April 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Champions Oncology reported $3M in long-term debt as of April 2026. That compares with $4.6M in the prior-year period — down 35.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Champions Oncology, and consider following CSBR for alerts when major investors trade the stock.

Champions Oncology is classified in the Healthcare sector. On long-term debt, it currently shows $3M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CSBR with unrelated industries.